Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2805)	5/3/2010 2:29:56 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

PBTH is up a modest 2.61% on volume of >309Ks almost 3x its ADV.<g> It traded at 10:10AM above its April19 H of $5.55 but is having a few down ticks since I started writing this note.<g> bigcharts.marketwatch.com The stock is benefiting from its report today of new preclinical data on its pipeline of drug candidates designed to reduce the dosing frequency of therapeutic proteins and peptides. The data will be discussed by its management at the 2010 BIO International Convention in Chicago on Wednesday and later at the Rodman & Renshaw 6th Annual Global Healthcare Conference in London and the Jefferies 2010 Global Life Sciences Conference in New York City. finance.yahoo.com On April 14 it received a $1.6M grant from the Israel Government for its hGH-CTP, a longer-acting version of human growth hormone. Phillip Frost is the chairman and largest investor on PBTH, and I decided in December to pick up some shares. I am also planing on picking up a few more.<g> bigcharts.marketwatch.com Bernard